Rong Jin Selected Research

5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dione

11/2020	Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
1/2019	PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rong Jin Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 03/2012
18	Stomach Neoplasms (Stomach Cancer) 02/2024 - 03/2012
13	Inflammation (Inflammations) 09/2023 - 07/2011
10	Asthma (Bronchial Asthma) 12/2023 - 05/2012
10	Stroke (Strokes) 01/2023 - 08/2010
7	Ischemic Stroke 01/2023 - 06/2010
7	Infarction (Infarctions) 01/2022 - 08/2007
6	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2014
6	Ischemia 10/2019 - 08/2007
5	Thrombosis (Thrombus) 01/2023 - 09/2014
5	Infections 12/2022 - 02/2007
5	Hypertrophic Cicatrix (Hypertrophic Scar) 03/2018 - 01/2013
4	Vitiligo 01/2024 - 01/2015
4	Brain Ischemia (Cerebral Ischemia) 01/2023 - 08/2007
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 04/2013
4	Hypoxia (Hypoxemia) 07/2022 - 04/2013
4	Embolic Stroke 01/2022 - 01/2018
4	Obesity 10/2021 - 02/2016
3	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 04/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 10/2018
3	Cerebral Hemorrhage 01/2022 - 01/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 03/2021 - 06/2017
3	Neointima 01/2018 - 01/2011
3	Carcinogenesis 11/2016 - 01/2015
3	Cicatrix (Scar) 03/2014 - 01/2013
3	Hyperplasia 12/2013 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 09/2009
2	Potassium Deficiency 04/2023 - 05/2022
2	Reperfusion Injury 01/2023 - 08/2007
2	Dysbiosis 10/2022 - 01/2019
2	Endotoxemia 10/2022 - 01/2019
2	Adenocarcinoma 10/2021 - 01/2018
2	Lymphoma (Lymphomas) 01/2021 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2021 - 04/2013
2	Melanoma (Melanoma, Malignant) 10/2020 - 11/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2014
2	Body Weight (Weight, Body) 05/2020 - 10/2018
2	Keloid 03/2018 - 01/2013
2	Necrosis 03/2018 - 02/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 07/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2007
8	CollagenIBA 03/2023 - 07/2011
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 06/2010
6	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023 - 08/2010
6	CurcuminIBA 01/2022 - 01/2014
5	OvalbuminIBA 09/2023 - 05/2012
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 12/2013
5	CytokinesIBA 01/2023 - 01/2013
5	Messenger RNA (mRNA)IBA 10/2021 - 08/2010
4	Long Noncoding RNAIBA 02/2024 - 11/2021
4	Therapeutic UsesIBA 09/2022 - 06/2007
4	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2018
3	Hormones (Hormone)IBA 10/2022 - 01/2003
3	Fluorouracil (Carac)FDA LinkGeneric 04/2022 - 04/2014
3	Da0324IBA 01/2022 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 01/2003
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2016
3	MicellesIBA 05/2020 - 02/2016
3	LigandsIBA 01/2020 - 02/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2011
3	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2013
3	Dextrans (Dextran)FDA Link 01/2018 - 08/2013
3	MicroRNAs (MicroRNA)IBA 01/2018 - 04/2013
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 04/2015
2	SuspensionsIBA 01/2024 - 02/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2021
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023 - 10/2019
2	Fish OilsIBA 12/2022 - 01/2020
2	IronIBA 09/2022 - 02/2017
2	SmokeIBA 01/2021 - 01/2020
2	5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA 11/2020 - 01/2019
2	Budesonide (Pulmicort)FDA LinkGeneric 05/2020 - 05/2012
2	FlavonoidsIBA 03/2020 - 10/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 12/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2008
2	Neuroprotective AgentsIBA 01/2019 - 12/2017
2	FibrinIBA 01/2018 - 12/2017
2	ApolipoproteinsIBA 01/2018 - 01/2015
2	P-SelectinIBA 01/2018 - 07/2011
2	CD40 Ligand (CD40L)IBA 01/2018 - 01/2013
2	1,4-bis(3-aminopropyl)piperazineIBA 01/2018 - 02/2016
2	Antineoplastic Agents (Antineoplastics)IBA 10/2017 - 04/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 02/2016
2	IntegrinsIBA 01/2017 - 02/2010
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2016 - 01/2015
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2015 - 03/2014

Therapy/Procedure

17	Therapeutics 08/2023 - 05/2008
7	Drug Therapy (Chemotherapy) 01/2023 - 09/2011
4	Transplantation 01/2024 - 07/2013
4	Immunotherapy 01/2023 - 01/2019
4	Thrombolytic Therapy 01/2022 - 06/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2022 - 09/2011
3	Sutures (Suture) 01/2022 - 09/2014
2	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2021
2	Mongolian Traditional Medicine 03/2021 - 10/2018
2	Radiotherapy 01/2019 - 09/2011
2	Intravenous Administration 10/2017 - 02/2016